Today: 13 lutego 2026
Subscribe
Search result

Phantom 4 RTK/feed/category/dji-mavic-3t-pl- Page 215

Meta Platforms stock drops as China reviews Manus AI deal, legal risks resurface

Meta Platforms stock drops as China reviews Manus AI deal, legal risks resurface

Meta shares fell 2.2% to $646.20 Wednesday after reports that Chinese officials are reviewing its $2 billion acquisition of AI startup Manus, raising the risk of regulatory delays. A U.S. appeals court also appeared skeptical of Meta’s bid to dismiss lawsuits over alleged harm to children. C.J. Mahoney was named chief legal officer, succeeding Jennifer Newstead, who will join Apple in March.
7 stycznia 2026
·
Strategy stock jumps on MSCI reprieve for bitcoin-treasury firms — but a key limit stays

Strategy stock jumps on MSCI reprieve for bitcoin-treasury firms — but a key limit stays

MSCI said it will not exclude digital asset treasury companies from its indexes in February 2026, pausing planned changes and opening a broader consultation. Shares of Strategy rose as much as 6% after hours and were last up 3.2% Wednesday morning, before trimming gains as bitcoin fell. MSCI will freeze certain index-weight inputs and halt new additions or size changes for affected stocks.
7 stycznia 2026
·
Meta stock drops after hours as court fight and smart-glasses supply squeeze keep traders cautious

Meta stock drops after hours as court fight and smart-glasses supply squeeze keep traders cautious

Meta Platforms shares dropped 1.8% to $648.69 in after-hours trading Wednesday amid investor rotation in big tech. The company paused international expansion of its Ray-Ban Display smart glasses due to U.S. demand and supply limits. Mark Zuckerberg named C.J. Mahoney as chief legal officer, replacing Jennifer Newstead, who will join Apple. U.S. job openings fell in November, while private payroll growth lagged forecasts.
7 stycznia 2026
·
AbbVie stock slides on $1.3 billion charge and outlook cut as deal chatter swirls

AbbVie stock slides on $1.3 billion charge and outlook cut as deal chatter swirls

AbbVie shares fell 4% to $224.13 in after-hours trading Thursday after the company cut its 2025 adjusted profit forecast and disclosed a $1.3 billion acquired R&D charge. The company lowered its full-year 2025 adjusted EPS outlook to $9.90–$9.94 from $10.61–$10.65. AbbVie denied takeover talks with Revolution Medicines. Investors await the company’s Feb. 4 earnings report for further guidance.
9 stycznia 2026
···
P&G stock rises after Crest toothpaste label deal in Texas puts PG back in focus

P&G stock rises after Crest toothpaste label deal in Texas puts PG back in focus

Procter & Gamble shares rose 2.5% to $141.53 after agreeing with Texas officials to change Crest children’s toothpaste packaging to clarify dosing. The rollout began Jan. 1, with P&G required to comply for five years. Piper Sandler started coverage at Neutral with a $150 target; TD Cowen cut its target to $150. Investors await Friday’s U.S. jobs report and P&G’s earnings on Jan. 22.
9 stycznia 2026
·
Tilray Brands (TLRY) stock jumps in premarket after record $218 mln quarter and net cash turn

Tilray Brands (TLRY) stock jumps in premarket after record $218 mln quarter and net cash turn

Tilray shares jumped nearly 9% to $9.95 in premarket trading after reporting fiscal Q2 revenue of $217.5 million and a narrowed net loss of $43.5 million. The company reaffirmed its full-year adjusted profit target and said it moved to a net cash position. Gross margin slipped, and craft beer sales remained under pressure. Traders are watching if the gains hold at the open.
9 stycznia 2026
··
Gabion Technologies IPO allotment today: How to check status as 768x demand puts SME listing in focus

Gabion Technologies IPO allotment today: How to check status as 768x demand puts SME listing in focus

Gabion Technologies India’s IPO share allotment is set for Jan. 9 after the offer drew 768 times subscription, with retail and non-institutional investors leading demand, BSE data showed. Shares are scheduled to list Jan. 13 on the BSE SME platform. Grey market prices hovered near 113 rupees, about 40% above the issue price, though this market is unregulated. The IPO was a fresh issue of 3.6 million shares at 76–81 rupees each.
9 stycznia 2026
··
P&G stock in focus after Crest toothpaste label change — what to watch before Jan. 22 earnings

P&G stock in focus after Crest toothpaste label change — what to watch before Jan. 22 earnings

Procter & Gamble will change Kid’s Crest toothpaste packaging after Texas officials said label artwork encouraged unsafe fluoride use by children. The rollout began Jan. 1 and must last five years. P&G shares closed up 0.24% at $141.87, then slipped 0.17% after hours. Investors await the Jan. 22 earnings call for updates on volumes, pricing, and regulatory scrutiny.
10 stycznia 2026
··
Hims & Hers stock slides as Amazon adds Wegovy pill, raising fresh pricing fears

Hims & Hers stock slides as Amazon adds Wegovy pill, raising fresh pricing fears

Hims & Hers Health shares dropped 6.4% to $31.69 Friday, extending a two-day slide to 11% after Amazon Pharmacy entered the Wegovy weight-loss pill market. BofA cut its price target and kept an Underperform rating, citing high 2026 estimates. The stock closed below key moving averages and neared oversold levels. The FDA previously warned the company over marketing claims for compounded weight-loss drugs.
10 stycznia 2026
··
Novo Nordisk Class B stock rises after Amazon adds Wegovy pill — what to watch before earnings

Novo Nordisk Class B stock rises after Amazon adds Wegovy pill — what to watch before earnings

Novo Nordisk shares rose 3% to 381.45 crowns in Copenhagen after Amazon Pharmacy began selling its new Wegovy weight-loss pill in the U.S. The pill, approved by the FDA in December, puts Novo ahead of Eli Lilly in the obesity pill market. About 8.95 million shares traded Friday, with prices ranging from 369.0 to 389.8 crowns. Novo will report full-year results on Feb. 4.
10 stycznia 2026
··
Eli Lilly stock (LLY) slips into JPM Week as Amazon adds rival Wegovy pill — what to watch next

Eli Lilly stock (LLY) slips into JPM Week as Amazon adds rival Wegovy pill — what to watch next

Eli Lilly shares fell 1.99% to $1,063.56 Friday, trailing a record-setting S&P 500. Amazon Pharmacy began selling Novo Nordisk’s Wegovy pill for $149 a month, raising concerns about pricing pressure in obesity drugs. Lilly is set to address investors at the J.P. Morgan Healthcare Conference on Tuesday.
11 stycznia 2026
······
Gurugram water supply disrupted after Basai pipeline damage as Delhi’s smog stays ‘very poor’

Gurugram water supply disrupted after Basai pipeline damage as Delhi’s smog stays ‘very poor’

A damaged pipeline cut water to large parts of Gurugram, affecting around 150 colonies and 50 societies, as GMDA halted supply from the Chandu Budhera plant and began repairs. Delhi’s air quality remained “very poor,” with Chandni Chowk recording an AQI of 395 and forecasts warning of continued smog through Jan. 13. Dense fog and cold-wave conditions reduced visibility and pushed temperatures as low as 3°C.
11 stycznia 2026
CompoSecure stock (CMPO) rallies into Monday as Husky deal nears — what to watch next

CompoSecure stock (CMPO) rallies into Monday as Husky deal nears — what to watch next

CompoSecure shares rose 3.6% to $22.17 Friday, extending a two-day rally ahead of its planned business combination with Husky Technologies. Shareholders approved the share issuance for the deal, which is expected to close in January pending regulatory sign-off. Fitch rated the company’s planned debt “BB+,” while Moody’s assigned a “B1” rating. The combined company is valued at about $7.4 billion.
12 stycznia 2026
·
Merck (MRK) stock slides as JPMorgan conference tests deal buzz and vaccine risk

Merck (MRK) stock slides as JPMorgan conference tests deal buzz and vaccine risk

Merck shares fell 1.1% to $109.27 Monday amid speculation over a possible $28–32 billion acquisition of Revolution Medicines, though no deal has been finalized. The SPDR S&P Biotech ETF dropped 2.1%. Analysts estimate Revolution’s RAS inhibitor drugs could generate over $10 billion in sales by 2035. Merck also faces a potential $2 billion annual revenue hit after U.S. vaccine schedule changes affecting Gardasil and RotaTeq.
12 stycznia 2026
··
1 … 213 214 215 216 217 … 278
Go toTop